{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:25:29Z","timestamp":1777404329917,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    is a predominant cause of pneumonia, sinusitis, bacteremia, meningitis and otitis media especially in children and the elderly. The emergence of antibiotic resistance and shift towards non-vaccine serotypes has compromised the efficacy of the treatment regime and available vaccines. The available polysaccharide-based vaccines confer protection against limited serotypes. In this study, we have conducted the experimental validation of a promising multi epitope vaccine candidate. The vaccine construct was cloned into pET-28a vector and expressed in\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    . The expression of the protein was induced, and its purification was carried out by the Ni-NTA affinity chromatography. Further, purified multiepitope protein was subjected to the SDS-PAGE and western blot analysis. The secondary structure was determined by circular dichroism spectroscopy, and it was observed to closely align with the predicted structure by Alpha fold. The hemolysis assay confirmed its safety and tolerability. The BALB\/c mice was administered with this multiepitope vaccine construct and immune response was evaluated. The antibody response was estimated and confirmed by western blot and ELISA analysis. The cytokine profiling assay revealed the involvement of interleukins, TNF-\u03b1, and GM-CSF. Together, this study provides the first experimental validation of a computationally designed multi-epitope vaccine against\n                    <jats:italic>S. pneumoniae<\/jats:italic>\n                    , demonstrating antibody titers, broad cytokine response, and absence of hemolytic toxicity.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1781081","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:10:01Z","timestamp":1771499401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenic insights and experimental validation of a multiepitope vaccine construct against Streptococcus pneumoniae"],"prefix":"10.3389","volume":"17","author":[{"given":"Yogeshwar","family":"Devarakonda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V. N. Janardhan","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunima","family":"Binu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirtimaan","family":"Syal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"B1","volume-title":"Pneumonia: A child dies of pneumonia every 43 seconds","year":"2024"},{"key":"B2","volume-title":"Streptococcus Pneumoniae","author":"Dion","year":"2023"},{"key":"B3","volume-title":"Pneumonia in children","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.191718","article-title":"Invasive pneumococcal disease","volume":"96","author":"Randle","year":"2011","journal-title":"Arch Dis childhood Educ Pract edition"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-017-1304-0","article-title":"Novel method for quantitative estimation of biofilms","volume":"74","author":"Syal","year":"2017","journal-title":"Curr Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.gpp3-0019-2018","article-title":"Streptococcus pneumoniae capsular polysaccharide","volume":"7","author":"Paton James","year":"2019","journal-title":"Microbiol Spectrum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.898815","article-title":"Influence of the polysaccharide capsule on the bactericidal activity of indolicidin on streptococcus pneumoniae","volume":"13","author":"Waz","year":"2022","journal-title":"Front Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c04889","article-title":"Biochemical and Immunological Insights into Capsular Polysaccharide of Streptococcus pneumoniae Serotype 38 (American Type 71)\u2500An Emerging Nonvaccine Serotype","volume":"10","author":"Reddy","year":"2025","journal-title":"ACS Omega"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies. An update and perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann Am Thorac Society"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.852475","article-title":"The history of pneumococcal conjugate vaccine development: dose selection","volume":"12","author":"Poolman","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1186\/s12889-023-15939-7","article-title":"Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: a repeated cross-sectional study of the INTEGO morbidity registry","volume":"23","author":"Janssens","year":"2023","journal-title":"BMC Public Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7774\/cevr.2017.6.1.38","article-title":"Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly","volume":"6","author":"Seo","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02432-2021","article-title":"A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany","volume":"59","author":"Bahrs","year":"2022","journal-title":"Eur Respir J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12866-024-03300-w","article-title":"High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland","volume":"24","author":"Rodriguez-Ruiz","year":"2024","journal-title":"BMC Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1187773","article-title":"Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D","volume":"14","author":"Afshari","year":"2023","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.832254","article-title":"Pneumococcal surface proteins as virulence factors, immunogens, and conserved vaccine targets","volume":"12","author":"Aceil","year":"2022","journal-title":"Front Cell Infection Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291203","article-title":"Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage","volume":"18","author":"Milani","year":"2023","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1278346","article-title":"Recent progress in pneumococcal protein vaccines","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12859-023-05175-6","article-title":"Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains","volume":"24","author":"Shafaghi","year":"2023","journal-title":"BMC Bioinf"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1212119","article-title":"Integrated immunoinformatics and subtractive proteomics approach for multi-epitope vaccine designing to combat S. pneumoniae TIGR4","volume":"10","author":"Ashgar","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2167123","article-title":"Multi epitope vaccine candidate design against Streptococcus pneumonia","volume":"41","author":"Devarakonda","year":"2023","journal-title":"J biomolecular structure dynamics"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.3390\/ijms23147899","article-title":"Development of a multi-epitope vaccine for mycoplasma hyopneumoniae and evaluation of its immune responses in mice and piglets","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac345","article-title":"BeStSel: webserver for secondary structure and fold prediction for protein CD spectroscopy","volume":"50","author":"Micsonai","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.848582","article-title":"Adaptive immune responses and immunity to SARS-coV-2","volume":"13","author":"Primorac","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10101596","article-title":"Immunogenicity and effectiveness of primary and booster vaccine combination strategies during periods of SARS-coV-2 delta and omicron variants","volume":"10","author":"Moghnieh","year":"2022","journal-title":"Vaccines"},{"key":"B28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.medj.2020.12.006","article-title":"A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice","volume":"2","author":"Silva-Cayetano","year":"2021","journal-title":"Med (New York NY)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2122585","article-title":"Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection","volume":"11","author":"Zhang","year":"2022","journal-title":"Emerging Microbes infections"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2019.20052","article-title":"Design and evaluation of a multi-epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice","volume":"149","author":"Ren","year":"2019","journal-title":"Swiss Med weekly"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00443-17","article-title":"Synthetic (p)ppGpp analogue is an inhibitor of stringent response in mycobacteria","volume":"61","author":"Syal","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae\u2019s virulence and host immunity: aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101446","DOI":"10.1016\/j.mcp.2019.101446","article-title":"Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy","volume":"48","author":"Dorosti","year":"2019","journal-title":"Mol Cell probes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1492268","article-title":"Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis","volume":"16","author":"Yun","year":"2025","journal-title":"Front Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040864","article-title":"Combination of recombinant proteins S1\/N and RBD\/N as potential vaccine candidates","volume":"11","author":"Mendoza-Ram\u00edrez","year":"2023","journal-title":"Vaccines"},{"key":"B36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pep.2014.10.007","article-title":"Design and construction of a chimeric multi-epitope gene as an epitope-vaccine strategy against ALV-J","volume":"106","author":"Xu","year":"2015","journal-title":"Protein Expression Purification"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.01.032","article-title":"Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans","volume":"57","author":"Fernandes","year":"2017","journal-title":"Int J Infect Diseases"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.12106","article-title":"Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B (126\u2013361)-target of RNAIII activating protein in mice","volume":"57","author":"Yu","year":"2013","journal-title":"Microbiol Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s13237-024-00478-2","article-title":"Novel edible multi-epitope vaccine construct against Enterococcus faecalis","volume":"68","author":"Devarakonda","year":"2025","journal-title":"Nucleus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c05975","article-title":"Expression, purification, and refolding of chikungunya virus full-length envelope E2 protein along with B-cell and T-cell epitope analyses using immuno-informatics approaches","volume":"7","author":"Shukla","year":"2022","journal-title":"ACS Omega"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/biom4010235","article-title":"Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies","volume":"4","author":"Yamaguchi","year":"2014","journal-title":"Biomolecules"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781081\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:10:02Z","timestamp":1771499402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781081\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2026.1781081"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1781081","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"1781081"}}